We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Allows Biosimilar Sponsors to Reference Non-EU Products in Applications
EMA Allows Biosimilar Sponsors to Reference Non-EU Products in Applications
October 8, 2012
The European Medicines Agency (EMA) will soon allow biosimilars sponsors to reference biologics made outside the European Economic Area (EEA) in some preclinical and clinical studies required for approval.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor